Biological activity and binding of estradiol to SK-Mel 23 human melanoma cells

Patients expressing estradiol receptors in melanoma cells have been reported to have a better prognosis. We therefore decided to investigate the in vitro effects of ß-estradiol and tamoxifen on the growth and tyrosinase activity of SK-Mel 23 human melanoma cells. Twenty-four-hour treatment with 0.4...

Full description

Bibliographic Details
Main Authors: Sarti M.S.M.V., Visconti M.A., Castrucci A.M.L.
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2004-01-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004000600016
_version_ 1811328186552680448
author Sarti M.S.M.V.
Visconti M.A.
Castrucci A.M.L.
author_facet Sarti M.S.M.V.
Visconti M.A.
Castrucci A.M.L.
author_sort Sarti M.S.M.V.
collection DOAJ
description Patients expressing estradiol receptors in melanoma cells have been reported to have a better prognosis. We therefore decided to investigate the in vitro effects of ß-estradiol and tamoxifen on the growth and tyrosinase activity of SK-Mel 23 human melanoma cells. Twenty-four-hour treatment with 0.4 nM ß-estradiol inhibited cell proliferation in 30% (0.70 ± 0.03 x 10(5) cells) and increased tyrosinase activity in 50% (7130.5 ± 376.5 cpm/10(5) cells), as compared to untreated cells (1.0 ± 0.05 x 10(5) cells and 4769 ± 25.5 cpm/10(5) cells, respectively). Both responses were completely (100%) blocked by 1 µM tamoxifen. Higher concentrations (up to 1.6 nM) or longer treatments (up to 72 h) did not result in a larger effect of the hormone on proliferation or tyrosinase activity. Competition binding assays demonstrated the presence of binding sites to [2,4,6,7-³H]-ß-estradiol, and that the tritiated analogue was displaced by the unlabeled hormone (1 nM to 100 µM, Kd = 0.14 µM, maximal displacement of 93%) or by 10 µM tamoxifen (displacement of 60%). ß-estradiol also increased the phosphorylated state of two proteins of 16 and 46 kDa, after 4-h treatment, as determined by Western blot. The absorbance of each band was 1.9- and 4-fold the controls, respectively, as determined with Image-Pro Plus software. Shorter incubation periods with ß-estradiol did not enhance phosporylation; after 6-h treatment with the hormone, the two proteins returned to the control phosphorylation levels. The growth inhibition promoted by estradiol may explain the better prognosis of melanoma-bearing women as compared to men, and open new perspectives for drug therapy.
first_indexed 2024-04-13T15:20:45Z
format Article
id doaj.art-1618d42927f649aa88b5644e4e328c82
institution Directory Open Access Journal
issn 0100-879X
0034-7310
language English
last_indexed 2024-04-13T15:20:45Z
publishDate 2004-01-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-1618d42927f649aa88b5644e4e328c822022-12-22T02:41:40ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X0034-73102004-01-01376901905Biological activity and binding of estradiol to SK-Mel 23 human melanoma cellsSarti M.S.M.V.Visconti M.A.Castrucci A.M.L.Patients expressing estradiol receptors in melanoma cells have been reported to have a better prognosis. We therefore decided to investigate the in vitro effects of ß-estradiol and tamoxifen on the growth and tyrosinase activity of SK-Mel 23 human melanoma cells. Twenty-four-hour treatment with 0.4 nM ß-estradiol inhibited cell proliferation in 30% (0.70 ± 0.03 x 10(5) cells) and increased tyrosinase activity in 50% (7130.5 ± 376.5 cpm/10(5) cells), as compared to untreated cells (1.0 ± 0.05 x 10(5) cells and 4769 ± 25.5 cpm/10(5) cells, respectively). Both responses were completely (100%) blocked by 1 µM tamoxifen. Higher concentrations (up to 1.6 nM) or longer treatments (up to 72 h) did not result in a larger effect of the hormone on proliferation or tyrosinase activity. Competition binding assays demonstrated the presence of binding sites to [2,4,6,7-³H]-ß-estradiol, and that the tritiated analogue was displaced by the unlabeled hormone (1 nM to 100 µM, Kd = 0.14 µM, maximal displacement of 93%) or by 10 µM tamoxifen (displacement of 60%). ß-estradiol also increased the phosphorylated state of two proteins of 16 and 46 kDa, after 4-h treatment, as determined by Western blot. The absorbance of each band was 1.9- and 4-fold the controls, respectively, as determined with Image-Pro Plus software. Shorter incubation periods with ß-estradiol did not enhance phosporylation; after 6-h treatment with the hormone, the two proteins returned to the control phosphorylation levels. The growth inhibition promoted by estradiol may explain the better prognosis of melanoma-bearing women as compared to men, and open new perspectives for drug therapy.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004000600016SK-Mel 23 cell lineHuman melanomaß-estradiolTamoxifenCell proliferationTyrosinase activity
spellingShingle Sarti M.S.M.V.
Visconti M.A.
Castrucci A.M.L.
Biological activity and binding of estradiol to SK-Mel 23 human melanoma cells
Brazilian Journal of Medical and Biological Research
SK-Mel 23 cell line
Human melanoma
ß-estradiol
Tamoxifen
Cell proliferation
Tyrosinase activity
title Biological activity and binding of estradiol to SK-Mel 23 human melanoma cells
title_full Biological activity and binding of estradiol to SK-Mel 23 human melanoma cells
title_fullStr Biological activity and binding of estradiol to SK-Mel 23 human melanoma cells
title_full_unstemmed Biological activity and binding of estradiol to SK-Mel 23 human melanoma cells
title_short Biological activity and binding of estradiol to SK-Mel 23 human melanoma cells
title_sort biological activity and binding of estradiol to sk mel 23 human melanoma cells
topic SK-Mel 23 cell line
Human melanoma
ß-estradiol
Tamoxifen
Cell proliferation
Tyrosinase activity
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004000600016
work_keys_str_mv AT sartimsmv biologicalactivityandbindingofestradioltoskmel23humanmelanomacells
AT viscontima biologicalactivityandbindingofestradioltoskmel23humanmelanomacells
AT castrucciaml biologicalactivityandbindingofestradioltoskmel23humanmelanomacells